Global MHealth Market - 2024-2031

The global mHealth market reached US$ 61.65 billion in 2023 and is expected to reach US$ 162.20 billion by 2031, growing at a CAGR of 12.9% during the forecast period 2024-2031.

mHealth (mobile health) refers to the utilization of mobile phones and other wireless technologies in the field of healthcare. One of the primary applications of mHealth is to educate consumers about preventive healthcare services through mobile devices. Beyond education, mHealth also plays a vital role in various areas such as disease surveillance, treatment support, monitoring epidemic outbreaks, and managing chronic diseases. This diverse range of applications highlights the significant impact of mobile technology on enhancing healthcare delivery and improving patient outcomes.

Market Dynamics: Drivers & Restraints

Increasing usage of digital health solutions

Increasing usage of digital health solutions is expected to drive the mHealth market. This is due to the increasing technological advancements, increasing digital health solutions, and rising real-time results that are expected to drive the mHealth market growth. The growth of telehealth services is significantly boosting the adoption of mHealth solutions, particularly in highly advanced countries and regions. According to the National Institute of Health in April 2024, it is stated that Data from the United States suggests that only 38% of people over the age of 65 have used mHealth apps to monitor their health.

These digital health solutions facilitate remote consultations and ongoing health monitoring, thereby enhancing both accessibility and efficiency in healthcare delivery. Furthermore, innovations in wearable technology, including smartwatches and fitness trackers, are expanding the functionality of mHealth applications by enabling real-time tracking of essential health metrics. For instance, in October 2023, Cedars-Sinai announced that it is expanding virtual healthcare for patients in California through a new mobile app that allows individuals to quickly and easily access Cedars-Sinai experts for sick, chronic, and preventive care. Through the new virtual healthcare option Cedars-Sinai Connect, healthcare professionals are available 24/7 for urgent issues, and same-day appointments are accessible for primary care by reducing wait times.

This integration of telehealth and wearable devices is transforming the mHealth market, making it a vital component of modern healthcare that caters to the needs of diverse populations and improves overall health outcomes.

With the growing smartphone usage, the adoption of digital health solutions including mHealth solutions is expected to rise. There is a growing usage of smartphones among individuals. For instance, according to the Global Mobile Internet Connectivity, it is mentioned that mobile penetration is projected to increase to 6.3 billion by 2030, encompassing 74% of the global population.

Data privacy and security concerns

mHealth market's growth is significantly hindered by data privacy and security concerns arising from vulnerabilities in app design, insufficient protections for user data, developer knowledge gaps, regulatory compliance challenges, and user behavior. Addressing these issues is essential for fostering trust among consumers and promoting broader adoption of mHealth solutions. Without enhanced security measures and greater transparency regarding data handling practices, the potential advantages of mHealth technologies may go unrealized. Thus, the above factors could hinder the market growth by reducing the adoption of mHealth solutions.

Segment Analysis

The global mHealth market is segmented based on product type, application, end-user and region.

Product Type:

mHealth devices segment is expected to dominate the MHealth market share

mHealth devices segment is expected to dominate over mHealth apps. This is due to the growing adoption of wearables over the usage of mHealth apps. Individuals are often seeking convenience and effectiveness in the devices than mHealth apps. As consumers place greater emphasis on preventive healthcare, the demand for devices that support this approach is growing. mHealth devices are particularly effective in enabling users to proactively monitor their health. For instance, wearables can identify early signs of chronic conditions, allowing users to seek medical advice before problems worsen. These factors are encouraging users to adopt to mHealth devices.

Several companies are introducing advanced solutions that integrate advanced technologies and intelligence and are attracting consumers. For instance, in August 2022, GOQii introduced Smart Vital Ultra and GOQii Stream devices targeted at young adults and youth, encouraging them to lead a healthy and active lifestyle.

In November 2022, Sony launched new wearable motion trackers that let its wearer's experience metaverse up and close. Shipped in an oval-shaped charging case, the Mocopi consists of six differently colored motion trackers that have to be worn on the head, both wrists, hips, and ankles.

Geographical Analysis

North America is expected to hold a significant position in the mHealth market share

North America is expected to dominate the mHealth market due to the rising technological advancements, increasing adoption of mobile health apps and services and the presence of a large number of players in the region.

There is a widespread adoption of smartphones in the region. With the increasing number of smartphones, the number of mobile health apps installed and subscriptions are increasing.

With the growing geriatric population, the demand for mHealth solutions is rising because of their effectiveness in providing remote patient monitoring. There is a rising geriatric population in the region. For instance, the Population Reference Bureau in 2024 stated that the number of Americans ages 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050 (a 47% increase), and the 65-and-older age group's share of the total population is projected to rise from 17% to 23%. The use of mHealth solutions increases with this rise.

The rising incidence of chronic diseases is also contributing to the growth of the market and is expected to increase the demand for mHealth solutions. The increasing incidence of these diseases is encouraging the market players to innovate new mHealth solutions which is contributing the market growth.

Collaborations between key companies and healthcare providers are leading to the development of advanced mobile health applications that cater to diverse health needs, from chronic disease management to fitness tracking. For instance, in June 2024, Cleveland Clinic and app developer FitNow, Inc. have launched the Cleveland Clinic Diet app, which offers health and diet advice built upon evidence-based nutrition science and clinical success, paired with a comprehensive food and fitness tracker. The app provides individualized guided support with the input of Cleveland Clinic health experts to help users make sustainable changes to their lifestyle and dietary habits for better health and well-being.

Asia-Pacific is growing at the fastest growing pace in the mHealth market

The rapid expansion of the mHealth market in the Asia-Pacific region is fueled by a combination of dynamic factors, making it a key player in the global landscape. One significant driver is the increasing prevalence of chronic diseases, which has heightened the demand for effective health management solutions.

Widespread adoption of mobile technology in healthcare, or mHealth, is now viewed as inevitable by more than half of doctors and healthcare payers in developed and emerging markets with over 60% in India. According to a new global study conducted for PwC Global Healthcare by the Economist Intelligence Unit (EIU), the pace of adoption will likely be led by emerging markets that rank highest among ten countries on a score of mHealth maturity.

Competitive Landscape

The major global players in the mHealth market include Medtronic, OMRON Healthcare, Inc., AliveCor, Inc., AirStrip Technologies, Inc, AgaMatrix, F. Hoffmann-La Roche AG, Abbott, LifeScan IP Holdings, LLC., eka.care, and BIOTRONIK SE & Co. KG among others.

• Why Purchase the Report?
• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global MHealth market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.